| Literature DB >> 33673566 |
Kanika Vanshylla1, Kathrin Held2,3, Tabea M Eser2,3, Henning Gruell1,4, Franziska Kleipass1, Ricarda Stumpf1, Kanika Jain1, Daniela Weiland1, Jan Münch5, Berthold Grüttner6, Christof Geldmacher2,3, Florian Klein1,4,7.
Abstract
Humanized mice are critical for HIV-1 research, but humanized mice generated from cord blood are inefficient at mucosal HIV-1 transmission. Most mucosal HIV-1 transmission studies in mice require fetal tissue-engraftment, the use of which is highly restricted or prohibited. We present a fetal tissue-independent model called CD34T+ with enhanced human leukocyte levels in the blood and improved T cell homing to the gut-associated lymphoid tissue. CD34T+ mice are highly permissive to intra-rectal HIV-1 infection and also show normal env diversification in vivo despite high viral replication. Moreover, mucosal infection in CD34T+ mice can be prevented by infusion of broadly neutralizing antibodies. CD34T+ mice can be rapidly and easily generated using only cord blood cells and do not require any complicated surgical procedures for the humanization process. Therefore, CD34T+ mice provide a novel platform for mucosal HIV-1 transmission studies as well as rapid in vivo testing of novel prevention molecules against HIV-1.Entities:
Keywords: broadly neutralizing antibodies; humanized mice; mucosal HIV-1 prevention
Year: 2021 PMID: 33673566 PMCID: PMC7997265 DOI: 10.3390/vaccines9030198
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X